276 related articles for article (PubMed ID: 1978640)
21. An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
Anton AH; Sherman BW; Lina AA; Acheson LS
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):89-92. PubMed ID: 8096204
[TBL] [Abstract][Full Text] [Related]
22. Abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability.
Yan KW; Tian XF; Wu YN; Cai M; Guo MT
Front Endocrinol (Lausanne); 2023; 14():1131564. PubMed ID: 37152944
[TBL] [Abstract][Full Text] [Related]
23. Perioperative management of 63 patients with pheochromocytoma.
Boutros AR; Bravo EL; Zanettin G; Straffon RA
Cleve Clin J Med; 1990 Oct; 57(7):613-7. PubMed ID: 2121390
[TBL] [Abstract][Full Text] [Related]
24. The intraoperative medical management of childhood pheochromocytoma.
Ellis D; Gartner JC
J Pediatr Surg; 1980 Oct; 15(5):655-9. PubMed ID: 6108356
[TBL] [Abstract][Full Text] [Related]
25. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.
Agrawal R; Mishra SK; Bhatia E; Mishra A; Chand G; Agarwal G; Agarwal A; Verma AK
World J Surg; 2014 Mar; 38(3):716-23. PubMed ID: 24233658
[TBL] [Abstract][Full Text] [Related]
26. Management of pheochromocytoma during pregnancy.
Leak D; Carroll JJ; Robinson DC; Ashworth EJ
Can Med Assoc J; 1977 Feb; 116(4):371-5. PubMed ID: 844020
[TBL] [Abstract][Full Text] [Related]
27. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
[TBL] [Abstract][Full Text] [Related]
28. Perioperative management of a patient with a malignant pheochromocytoma.
Miller D; Robblee JA
Can Anaesth Soc J; 1985 May; 32(3 Pt 1):278-82. PubMed ID: 4005679
[TBL] [Abstract][Full Text] [Related]
29. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
Ram CV; Meese R; Hill SC
Arch Intern Med; 1985 Nov; 145(11):2114-5. PubMed ID: 2865938
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative and postoperative management of adrenal masses].
Paragliola RM; Ricciato MP; Gallo F; De Rosa A; Ianni F; Locantore P; Senes P; Pontecorvi A; Corsello SM
G Chir; 2010; 31(6-7):332-5. PubMed ID: 20646386
[TBL] [Abstract][Full Text] [Related]
31. Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy.
Serri O; Comtois R; Bettez P; Dubuc G; Buu NT; Kuchel O
N Engl J Med; 1984 May; 310(19):1264-5. PubMed ID: 6709035
[No Abstract] [Full Text] [Related]
32. Predictors of hemodynamic instability during surgery for pheochromocytoma.
Kiernan CM; Du L; Chen X; Broome JT; Shi C; Peters MF; Solorzano CC
Ann Surg Oncol; 2014 Nov; 21(12):3865-71. PubMed ID: 24939623
[TBL] [Abstract][Full Text] [Related]
33. Hypertensive crisis in prazosin-treated pheochromocytoma.
Knapp HR; Fitzgerald GA
South Med J; 1984 Apr; 77(4):535-6. PubMed ID: 6710216
[TBL] [Abstract][Full Text] [Related]
34. Perioperative management of a patient with a nonresectable pheochromocytoma.
Badri M; Gibbons AV; Popii V; Yih D; Cohen-Stein DL; Patel SM
Endocr Pract; 2013; 19(3):e74-6. PubMed ID: 23425647
[TBL] [Abstract][Full Text] [Related]
35. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Takekoshi K; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Asada S; Kawata N; Naruse M
Endocr J; 2019 Dec; 66(12):1063-1072. PubMed ID: 31511435
[TBL] [Abstract][Full Text] [Related]
36. Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.
Habbe N; Ruger F; Bojunga J; Bechstein WO; Holzer K
World J Surg; 2013 May; 37(5):1141-6. PubMed ID: 23381676
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.
Naruse M; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Harada T; Kawata N; Takekoshi K
Endocr J; 2018 Mar; 65(3):359-371. PubMed ID: 29353821
[TBL] [Abstract][Full Text] [Related]
38. [Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases].
Pan DL; Li HZ; Ji ZG; Zeng ZP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1403-5. PubMed ID: 16029653
[TBL] [Abstract][Full Text] [Related]
39. Phenoxybenzamine is no longer the standard agent used for alpha blockade before adrenalectomy for pheochromocytoma: A national study of 552 patients.
Kuo EJ; Chen L; Wright JD; McManus CM; Lee JA; Kuo JH
Surgery; 2023 Jan; 173(1):19-25. PubMed ID: 36167697
[TBL] [Abstract][Full Text] [Related]
40. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1981 Feb; 21(2):81-9. PubMed ID: 7009139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
